
167.99BBRL
Type
Common Stock
Exchange
SA
Currency Code
BRL
Currency Name
Brazilian real
Country Name
Brazil
Country ISO
BR
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
17.58
PEG Ratio
2.19
Book Value
97.16
Dividend Share
3.19
Dividend Yield
0.93%
Earnings Share
18.9
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
29,735,999,488
Gross Profit TTM
23,601,000,448
EBITDA
14,737,999,872
Profit Margin
30.99%
Return On Assets TTM
13.29%
Return On Equity TTM
43.36%
Revenue Per Share TTM
23.923
Qtly Revenue Growth YOY
4.40%
Diluted Eps TTM
18.9
Qtly Earnings Growth YOY
54.80%
Trailing PE
17.58
Forward PE
15
Price Sales TTM
27.7391
Price Book MRQ
7.0336
Enterprise Value Revenue
6
Enterprise Value EBITDA
12
71.85
0.67%195.48
-4.81%82.00
-3.63%87.27
-3.07%144.61
-2.34%32.26
-1.83%31.43
-1.63%80.00
-1.59%82.40
-0.50%323.60
-0.34%